Loading patent…
AssigneesMitsubishi Pharma Corporation, Sanofi-Synthelabo
InventorsFumiaki Uehara, Keiichi Aritomo, Aya Shoda, Shinsuke Hiki, Masahiro Okuyama, Yoshihiro Usui, Mitsuru Ooizumi, Kazutoshi Watanabe, Koichi Yamakoshi
Estimating the term…
a pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof having inhibitory activity against tau protein kinase 1: wherein R1 represents a C1-C12 alkyl group which may be substituted; R represents, for example, a group represented by the following formula (II): wherein R2 and R3 independently represent a hydrogen atom or a C1-C8 alkyl group; R4 represents a benzene ring which may be substituted, a naphthalene ring which may be substituted, an indan ring which may be substituted, a tetrahydronaphthalene ring which may be substituted, or an optionally substituted heterocyclic ring having 1 to 4 heteno atoms selected from the group consisting of oxygen atom, sulfur atom and nitrogen atom, and having 5 to 10 ring-constituting atoms in total.
A pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof:
A pyrimidone derivative which is selected from the group consisting of:
A pyrimidone derivative which is selected from the group consisting of:
A pyrimidone derivative which is selected from the group consisting of:
A pyrimidone derivative which is selected from the group consisting of:
A pyrimidone derivative represented by formula (VI) or a salt thereof, or a solvate thereof or a hydrate thereof:
A pyrimidone derivative represented by formula (VII) or a salt thereof, or a solvate thereof or a hydrate thereof:
Dependencies are inferred from the claim text.